Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Methionyl-tRNA synthetase (MetRS) is an essential enzyme that catalyzes the attachment of methionine to its cognate tRNA (tRNAMet). This process is critical for protein biosynthesis, ensuring that methionine is correctly incorporated during translation initiation. In mammals, MetRS interacts with AIMP3/p18, influencing DNA repair and tumor suppression. It is part of a larger multi-tRNA synthetase complex (MSC) involved in cell growth and stress responses. The enzyme's structure includes a catalytic Rossmann fold, KMSKS domain, and species-specific extensions that mediate interactions with other proteins or enhance activity.
Catalyzes the covalent linkage of methionine to tRNAMet using ATP
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Methionyl-tRNA Synthetase (MetRS).